January 2016, Aspen announced that due to production problems, tablets with 0.025mg Thyrax would not be available from mid-2106. Later, it was announced that this shortage would last well into 2017.  People who took this medication had to switch to alternatives, which led to 30% of them experiencing side-effects because of this shift.<ref>{{Cite web|url=https://www.knmp.nl/downloads/eindrapport-nivel-tekort-thyrax-duotab.pdf|title=Report about the effects on patients that had to switch from thyrax|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
